Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy.

Front Cardiovasc Med · 2021 · PMC8632763 · PMID 34869685

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

6.6%, adjusted HR: 0.33, 95% CI: 0.09–1.17, P = 0.083), this did not reach statistical significance as shown in Figure 2 .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.